需要考虑药品投资决策的市场准入:一本入门书
Sreeram V Ramagopalan1, Catherine Bacon2, Mel Walker3
1Centre for Pharmaceutical Medicine Research, King's College London, London, SE1 9NH, UK.
Journal of comparative effectiveness research
|April 4, 2025
概括
生物技术投资者必须优先考虑市场准入,并获得监管部门的批准,以获得成功的药物商业化. 战略性市场准入规划对于吸引投资和确保药物吸收,定价和报销至关重要.
科学领域:
- 医药领域的投资.
- 卫生经济学 卫生经济学
- 毒品的商业化 毒品的商业化
背景情况:
- 生物技术和制药投资者在评估药物开发投资时,传统上专注于监管批准成功率.
- 这种关注忽视了市场准入在实现预计销售中的关键作用,正如最近的血友病基因治疗病例所示.
- 最近的监管变化,包括美国通货膨胀减缓法案和欧盟联合临床评估,影响了市场准入动态.
研究的目的:
- 检查市场准入因素在制药投资决策中的关键作用.
- 突出市场准入策略如何通过定价,报销和采用影响商业成功.
- 强调需要将市场准入规划纳入投资战略的必要性.
主要方法:
- 审查生物技术/制药行业当前的投资估值实践.
- 分析最近的药物商业化案例研究,特别是在基因治疗中.
- 检查新监管格局对市场准入的影响.
主要成果:
- 仅仅通过监管机构的批准并不能保证商业成功;市场准入结果至关重要.
- 有效的市场准入策略通过改进定价,报销和采用,直接提高商业成功.
- 清晰的市场准入计划为投资者提供了更清晰的商业成功道路,从而鼓励投资.
结论:
- 药品投资决策必须从一开始就纳入市场准入方面的考虑.
- 将市场准入视为战略能力对于吸引投资至关重要.
- 在全球范围内,复杂的医疗技术评估需要采取积极的市场准入方法,以获得成功的药物开发和商业化.
相关概念视频
Bioequivalence: Overview
892
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
892
Biopharmaceutics and Pharmacokinetics: Overview
1.8K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.8K
Clinical Trials: Overview
2.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.5K
Drug Nomenclature
1.5K
During the development of a new pharmaceutical, the manufacturer initially assigns a code name to the drug. Once approved, the drug receives a United States Adopted Name (USAN)—a generic, nonproprietary designation. Upon being listed in the United States Pharmacopeia, this nonproprietary name becomes the drug's official name. Additionally, the manufacturer assigns a proprietary name or trademark, which serves as the brand name under which the drug is marketed. It is worth noting that...
1.5K
Factors Influencing Drug Absorption: Pharmaceutical Parameters
104
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
104
Drug Control Governance: Regulatory Bodies and Their Impact
128
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
128


